Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

18.90 

0.70 3.9%

as of Oct 04 '22

52 Week Range:

12.20 22.00


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Aevis Victoria SA engages in healthcare, hospitality, lifestyle, and infrastructure sectors in Switzerland. The company operates through Hospitals, Hospitality, Telemedicine, and Real Estate segments. It operates 22 hospitals with 1,496 beds; manages with a total of 941 rooms with a total rentable surface of 188,109 sqm. It also provides telemedicine, and ambulance and day clinic services. In addition, it engages in the patient hotel, better aging, radiology institute, pharmacy, ophthalmology, real estate management, stem cells, cosmetics, and publishing businesses, as well as organizes seminars. The company is headquartered in Fribourg, Switzerland. Aevis Victoria SA is a subsidiary of M.R.S.I. Medical Research, Services and Investments S.A.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Earnings BIT 23.00
27.69
23.35
31.46
31.27
16.77
-12.86
-35.37
-24.14
growth rate 20.4% -15.7% 34.7% -0.6% -46.4% -100.0% 0.0% 0.0%
Avg.PE 126.39
429.29
445.71
445.71
5.77
growth rate 239.7% 3.8% 0.0% -76.5%
Balance Sheet Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Acct.Receivable 107.00
144.00
162.21
186.31
188.64
184.56
210.96
215.02
214.40
286.31
growth rate 34.6% 12.7% 14.9% 1.3% -2.2% 14.3% 1.9% -0.3% 33.5%
Acct.Payable 59.00
74.00
66.12
88.60
92.37
104.78
107.54
100.63
109.73
130.97
growth rate 25.4% -10.7% 34.0% 4.3% 13.4% 2.6% -6.4% 9.0% 19.4%
Cur.Assets 136.00
187.00
227.27
216.89
232.87
238.31
266.47
282.84
309.37
383.16
growth rate 37.5% 21.5% -4.6% 7.4% 2.3% 11.8% 6.1% 9.4% 23.9%
Total Assets 734.00
1,006.00
1,288.60
1,386.06
1,719.76
1,750.64
1,854.88
1,190.56
1,529.95
1,730.43
growth rate 37.1% 28.1% 7.6% 24.1% 1.8% 6.0% -35.8% 28.5% 13.1%
Cash 10.00
29.00
48.57
13.07
15.21
18.19
34.37
40.24
65.56
63.42
growth rate 190.0% 67.5% -73.1% 16.4% 19.6% 89.0% 17.1% 62.9% -3.3%
Inventory 12.00
14.00
16.49
17.51
19.20
20.44
21.15
26.74
29.41
33.44
growth rate 16.7% 17.8% 6.2% 9.6% 6.5% 3.4% 26.4% 10.0% 13.7%
Cur.Liabilities 309.00
334.00
139.65
257.88
179.69
287.92
342.61
260.59
384.43
544.28
growth rate 8.1% -58.2% 84.7% -30.3% 60.2% 19.0% -23.9% 47.5% 41.6%
Liabilities 573.00
773.00
969.40
1,085.51
1,338.26
1,372.49
1,409.85
746.73
1,110.31
1,144.98
growth rate 34.9% 25.4% 12.0% 23.3% 2.6% 2.7% -47.0% 48.7% 3.1%
LT Debt 197.00
353.00
708.09
710.21
993.19
912.14
898.99
407.24
648.32
522.01
growth rate 79.2% 100.6% 0.3% 39.9% -8.2% -1.4% -54.7% 59.2% -19.5%
Equity 270.46
300.73
310.73
308.10
324.23
386.31
361.23
485.92
growth rate 11.2% 3.3% -0.9% 5.2% 19.2% -6.5% 34.5%
Common Shares 311.00
71.98
75.18
75.66
78.09
78.59
80.39
83.50
84.53
growth rate -76.9% 4.4% 0.7% 3.2% 0.6% 2.3% 3.9% 1.2%
Cash Flow Statement Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Capital Expenditures 67.00
149.00
56.13
124.39
45.93
55.23
90.77
91.24
296.03
42.13
growth rate 122.4% -62.3% 121.6% -63.1% 20.3% 64.4% 0.5% 224.5% -85.8%
Cash Dividends 7.83
7.67
8.10
8.33
8.36
73.83
growth rate -2.0% 5.7% 2.8% 0.3% 783.6%
Cash From OA 13.00
42.00
18.63
36.58
55.60
60.09
16.39
18.86
23.77
33.53
growth rate 223.1% -55.6% 96.3% 52.0% 8.1% -72.7% 15.1% 26.0% 41.1%
Sale Purchase of Stock 1.04
2.72
2.72
13.42
growth rate 160.7% 0.0% 393.1%
FCF -54.00
-107.00
-37.50
-87.81
9.68
4.87
-74.39
-72.38
-272.26
-8.59
growth rate 0.0% 0.0% 0.0% 100.0% -49.7% -100.0% 0.0% 0.0% 0.0%
Income Statement Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Sales 307.00
399.00
484.85
508.09
517.12
582.51
577.13
623.20
624.94
744.92
growth rate 30.0% 21.5% 4.8% 1.8% 12.7% -0.9% 8.0% 0.3% 19.2%
Op.Income 4.00
23.00
27.69
23.35
31.46
31.27
16.77
-12.86
-35.37
-24.14
growth rate 475.0% 20.4% -15.7% 34.7% -0.6% -46.4% -100.0% 0.0% 0.0%
IBT 6.02
0.48
4.60
7.94
-2.41
159.34
-34.01
5.39
growth rate -92.0% 858.1% 72.5% -100.0% 100.0% -100.0% 100.0%
Net Income 4.00
9.00
5.75
3.77
2.31
-0.92
-8.66
163.20
-31.80
-4.27
growth rate 125.0% -36.1% -34.5% -38.8% -100.0% 0.0% 100.0% -100.0% 0.0%
Gross Profit 92.00
105.00
127.65
127.57
134.34
148.82
146.55
151.37
146.23
176.52
growth rate 14.1% 21.6% -0.1% 5.3% 10.8% -1.5% 3.3% -3.4% 20.7%

Quarterly Statements

Item Name Jun '19 Mar '21 Jun '21 Sep '21 Dec '21
Earnings BIT 3.64
-4.06
-4.06
-8.01
-8.01
growth rate -100.0% 0.0% 0.0% 0.0%
Balance Sheet Jun '19 Mar '21 Jun '21 Sep '21 Dec '21
Acct.Receivable 186.17
237.95
237.95
286.31
286.31
growth rate 27.8% 0.0% 20.3% 0.0%
Acct.Payable 80.18
92.53
92.53
130.97
130.97
growth rate 15.4% 0.0% 41.5% 0.0%
Cur.Assets 243.25
361.22
361.22
383.16
383.16
growth rate 48.5% 0.0% 6.1% 0.0%
Total Assets 1,234.85
1,590.74
1,590.74
1,730.43
1,730.43
growth rate 28.8% 0.0% 8.8% 0.0%
Cash 34.53
94.24
94.24
63.42
63.42
growth rate 172.9% 0.0% -32.7% 0.0%
Inventory 22.55
29.03
29.03
33.44
33.44
growth rate 28.8% 0.0% 15.2% 0.0%
Cur.Liabilities 230.56
280.46
280.46
544.28
544.28
growth rate 21.7% 0.0% 94.1% 0.0%
Liabilities 638.49
1,057.96
1,057.96
1,144.98
1,144.98
growth rate 65.7% 0.0% 8.2% 0.0%
LT Debt 329.11
718.44
718.44
522.01
522.01
growth rate 118.3% 0.0% -27.3% 0.0%
Equity 516.30
476.89
476.89
485.92
485.92
growth rate -7.6% 0.0% 1.9% 0.0%
Common Shares 78.59
83.50
83.50
84.53
84.53
growth rate 6.3% 0.0% 1.2% 0.0%
Cash Flow Statement Jun '19 Mar '21 Jun '21 Sep '21 Dec '21
Capital Expenditures 23.10
10.02
10.02
11.04
11.04
growth rate -56.6% 0.0% 10.2% 0.0%
Cash Dividends
growth rate
Cash From OA 3.57
1.88
1.88
14.89
14.89
growth rate -47.4% 0.0% 694.0% 0.0%
Sale Purchase of Stock
growth rate
FCF -19.53
-8.14
-8.14
3.85
3.85
growth rate 0.0% 0.0% 100.0% 0.0%
Income Statement Jun '19 Mar '21 Jun '21 Sep '21 Dec '21
Sales 153.69
164.86
164.86
207.60
207.60
growth rate 7.3% 0.0% 25.9% 0.0%
Op.Income 3.64
-4.06
-4.06
-8.01
-8.01
growth rate -100.0% 0.0% 0.0% 0.0%
IBT 93.72
8.13
8.13
-5.44
-5.44
growth rate -91.3% 0.0% -100.0% 0.0%
Net Income 96.16
6.29
6.29
-8.43
-8.43
growth rate -93.5% 0.0% -100.0% 0.0%
Gross Profit 47.99
52.04
52.04
36.22
36.22
growth rate 8.5% 0.0% -30.4% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (31.68)

YOY Growth Grade:

E (24.87)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

Current EPS is negative, therefore value price cannot be calculated.

PE and EPS

Historical Current Forward
PE 5.77 -47.25
EPS / Growth -85.1% -0.40

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 14.2%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 7.6% 7.6%
Future PE 0.01 3.85 7.01
Future EPS 0.00 0.00 0.00
Value Price
MOS %
0.00
-100.0%
0.00
-100.0%
0.00
-100.0%
MOS Price 0.00 0.00 0.00
IRT 99.00 99.00 99.00

Graham Number:

Current EPS is negative, therefore Graham Number cannot be calculated.
NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.